Region:
India
Category:
Society

Fire at Serum Institute of India under control, no casualty; Covishield production safe 

  • Fire at Serum Institute of India under control, no casualty; Covishield production safe 
    Vaccine production not hit. Fire at Serum Institute of India under control, no casualty; Covishield production safe 
Region:
India
Category:
Society
Publication date:
Print article

Vaccine production not hit. The company is involved in producing Covid-19 vaccine Covishield – developed by Oxford University and AstraZeneca – which has been given emergency use authorisation in India recently and is being used for inoculation in the country's mega vaccination drive.

A major fire has broken out at a building in the Serum Institute of India's Pune campus. This is, however, not the building where Covishield vaccine is being manufactured. Officials have said the Covid vaccine production has not been affected by the fire.

Amajor fire has broken out at a plant of the Serum Institute of India (SII) in Manjri area of Pune. Ten fire tenders are on the spot and are trying to douse the flames. One team of the National Disaster Response Force has also been rushed to control the fire that broke out around 2.45 pm. The cause of the fire at the Serum Institute plant is not yet known.

The fire broke out at an under-construction building at the Serum Institute's premises. Sources said initially four people were trapped inside of which three have been rescued.

The Serum Institute of India, the world's largest vaccine manufacturer, is manufacturing the Covishield vaccine developed by the Oxford University and AstraZeneca. Covishield is one of the two Covid-19 vaccines that have been granted emergency use approval in India.

Officials said the manufacturing unit of Covishield is safe and has not been affected by the fire.